BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 10808687)

  • 1. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
    Kurathong P; Jesdapatarakul S
    J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.
    Kumar NS; Singh AK; Mishra RN; Prakash J
    J Assoc Physicians India; 2004 Jun; 52():454-8. PubMed ID: 15645954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
    Hino S; Takemura T; Okada M; Murakami K; Yagi K; Fukushima K; Yoshioka K
    Am J Kidney Dis; 1998 Jun; 31(6):932-9. PubMed ID: 9631836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
    Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
    J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome.
    Trachtman H; Greenbaum LA; McCarthy ET; Sharma M; Gauthier BG; Frank R; Warady B; Savin VJ
    Am J Kidney Dis; 2004 Oct; 44(4):604-10. PubMed ID: 15384010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgM nephropathy: clinical picture and long-term prognosis.
    Myllymäki J; Saha H; Mustonen J; Helin H; Pasternack A
    Am J Kidney Dis; 2003 Feb; 41(2):343-50. PubMed ID: 12552495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
    Opastirakul S; Chartapisak W
    J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
    Caletti MG; Gallo G; Zumino D; Díaz MA; Vitacco M
    Bol Med Hosp Infant Mex; 1981; 38(3):457-72. PubMed ID: 7271977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
    Sinha MD; MacLeod R; Rigby E; Clark AG
    Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
    Jha V; Ganguli A; Saha TK; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V
    J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotic syndrome in African children: lack of evidence for 'tropical nephrotic syndrome'?
    Doe JY; Funk M; Mengel M; Doehring E; Ehrich JH
    Nephrol Dial Transplant; 2006 Mar; 21(3):672-6. PubMed ID: 16326742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome.
    Andersen RF; Rubak S; Jespersen B; Rittig S
    Scand J Urol Nephrol; 2009; 43(5):409-15. PubMed ID: 19921987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A follow up study of adult nephrotic syndrome in Nigerians: outcome and predictors of endstage renal failure.
    Ojogwu LI; Ukoli FA
    Afr J Med Med Sci; 1993 Jun; 22(2):43-50. PubMed ID: 7839896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.
    Simmonds J; Grundy N; Trompeter R; Tullus K
    Arch Dis Child; 2010 Feb; 95(2):146-9. PubMed ID: 20172895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of membranous lupus nephritis.
    Moroni G; Maccario M; Banfi G; Quaglini S; Ponticelli C
    Am J Kidney Dis; 1998 Apr; 31(4):681-6. PubMed ID: 9531186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.